A Critical Role for OX40 in T Cell-mediated Immunopathology during Lung Viral Infection

Journal of Experimental Medicine

Volumn 198, Issue 8, 2003, Pages 1237-1242

  Humphreys, Ian R ^a   Walz, Gerhard ^a   Edwards, Lorna ^a   Rae, Aaron ^a   Hill, Sue ^b   Hussell, Tracy ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Cantab Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Costimulation; Inflammation; Influenza; Weight loss

Indexed keywords

CD134 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CACHEXIA; CONTROLLED STUDY; FEMALE; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFLUENZA VIRUS A; LUNG INFECTION; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 0142218995     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030351     Document Type: Article

References (27)

1. Murray, C.J., and A.D. Lopez. 1997. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 349:1436-1442.
2. Curwen, M., K. Dunnell, and J. Ashley. 1990. Hidden influenza deaths. Br. Med. J. 300:896.
3. Doherty, P.C., D.J. Topham, R.A. Tripp, R.D. Cardin, J.W. Brooks, and P.G. Stevenson. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
4. Enelow, R.I., A.Z. Mohammed, M.H. Stoler, A.N. Liu, J.S. Young, Y.H. Lou, and T.J. Braciale. 1998. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J. Clin. Invest. 102:1653-1661.
5. Hussell, T., A. Pennycook, and P.J.M. Openshaw. 2001. Inhibition of tumour necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31:2566-2573.
6. Gramaglia, I., A.D. Weinberg, M. Lemon, and M. Croft. 1998. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:6510-6517.
7. Maxwell, J.R., A. Weinberg, R.A. Prell, and A.T. Vella. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-112.
8. Rogers, P.R., J. Song, I. Gramaglia, N. Killeen, and M. Croft. 2001. TI-OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 15:445-455.
9. Flynn, S., K.M. Toellner, C. Raykundalia, M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188:297-304.
10. Stuber, E., M. Neurath, D. Calderhead, H.P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 2:507-521.
11. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M.F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity. 11:699-708.
12. Jember, A.G., R. Zuberi, F.T. Liu, and M. Croft. 2001. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J. Exp. Med. 193:387-392.
13. Malmstrom, V., D. Shipton, B. Singh, A. Al-Shamkhani, M.J. Puklavec, A.N. Barclay, and F. Powrie. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166:6972-6981.
14. Higgins, L.M., S.A. McDonald, N. Whittle, N. Crockett, J.G. Shields, and T.T. Macdonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162:486-493.
15. Weinberg, A.D., K.W. Wegmann, C. Funatake, and R.H. Whitham. 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818-1826.
16. Taylor, L., M. Bachler, I. Duncan, S. Keen, R. Fallon, C. Mair, T.T. McDonald, and H. Schwartz. 2002. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions. J. Leukoc. Biol. 72:522-529.
17. Hussell, T., L.C. Spender, A. Georgiou, A. O'Garra, and P.J.M. Openshaw. 1996. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus. J. Gen. Virol. 77:2447-2455.
18. Wang, Q., N. Strong, and N. Killeen. 2001. Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene. J. Exp. Med. 194:1721-1730.
19. Alwan, W.H., F.M. Record, and P.J.M. Openshaw. 1992. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus: comparison with the effects of CD8+ cells. Clin. Exp. Immunol. 88:527-536.
20. Stevenson, P.G., S. Hawke, and C.P., Bangham. 1996. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J. Immunol. 157:3065-3073.
21. Baum, P.R., R.B. Gayle, III, F. Ramsdell, S. Srinivasan, R.A. Sornensen, M.L. Watson, M.F. Seldin, E. Baker, G.R. Sutherland, and K.N. Clifford. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:3992-4001.
22. Stuber, E., and W. Strober. 1996. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979-989.
23. Weinberg, A.D., A.T. Vella, and M. Croft. 1998. OX-40: life beyond the effector T cell stage. Semin. Immunol. 10:471-480.
24. Dong, L., I. Mori, M.J. Hossain, and Y. Kimura. 2000. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J. Infect. Dis. 182:391-396.
25. Pippig, S.D., C. Pena-Rossi, J. Long, W.R. Godfrey, D.J. Fowell, S.L. Reiner, M.L. Birkeland, R.M., Locksley, A.N. Barclay, and N. Killeen. 1999. Robust B cell immunity but impaired T cefl proliferation in the absence of CD134 (OX40).J. Immunol. 163:6520-6529.
26. Lumsden, J.M., J.M. Roberts, N.L. Harris, R.J. Peach, and F. Ronchese. 2000. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J. Immunol. 164:79-85.
27. Walzl, G., S. Matthews, S. Kendall, J.C. Gutierrez-Ramos, A.J. Coyle, P.J. Openshaw, and T. Hussell. 2001. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J. Exp. Med. 193:785-792.